A review of using Traditional Chinese Medicine in the management of glaucoma and cataract

References

• Beebe DC. Maintaining transparency: a review of the developmental physiology and pathophysiology of two avascular tissues. Semin Cell Dev Biol. 2008; 19: 125–133. doi:10.1016/j.semcdb.2007.08.014.
   PubMed Web of Science ®Google Scholar
• Selvam S, Kumar T, Fruttiger M. Retinal vasculature development in health and disease. Prog Retin Eye Res. 2018; 63: 1–19. doi:10.1016/j.preteyeres.2017.11.001.
   PubMed Web of Science ®Google Scholar
• Łatka P, Nowakowska D, Nowomiejska K, et al. Adverse effect of UV radiation on eyes—a review. Ophthalmol J. 2018; 3: 63–67. doi:10.5603/OJ.2018.0033.
   Google Scholar
• Jaki Mekjavic P, Tipton MJ, Mekjavic IB. The eye in extreme environments. Exp Physiol. 2021; 106: 52–64. doi:10.1113/EP088594.
   PubMed Web of Science ®Google Scholar
• Lin CC, Chiu CC, Lee PY, et al. The adverse effects of air pollution on the eye: a review. Int J Environ Res Public Health. 2022; 19: 1186. doi:10.3390/ijerph19031186.
   PubMedGoogle Scholar
• Wasnik VB, Thool AR. Ocular gene therapy: a literature review with focus on Current clinical trials. Cureus. 2022; 14: e29533. doi:10.7759/cureus.29533.
   PubMed Web of Science ®Google Scholar
• Awwad S, Mohamed Ahmed AHA, Sharma G, et al. Principles of pharmacology in the eye. Br J Pharmacol. 2017; 174: 4205–4223. doi:10.1111/bph.14024.
   PubMed Web of Science ®Google Scholar
• Holland EJ, Darvish M, Nichols KK, et al. Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: a systematic literature review. Ocul Surf. 2019; 17: 412–423. doi:10.1016/j.jtos.2019.02.012.
   PubMed Web of Science ®Google Scholar
• Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017; 15: 575–628. doi:10.1016/j.jtos.2017.05.006.
   PubMed Web of Science ®Google Scholar
• Wolffsohn JS, Trave Huarte S, Jones L, et al. Clinical practice patterns in the management of dry eye disease: a TFOS international survey. Ocul Surf. 2021; 21: 78–86. doi:10.1016/j.jtos.2021.04.011.
   PubMed Web of Science ®Google Scholar
• Fabre M, Mateo L, Lamaa D, et al. Recent advances in age-related macular degeneration therapies. Molecules. 2022; 27: 27. doi:10.3390/molecules27165089.
   Web of Science ®Google Scholar
• Jemni-Damer N, Guedan-Duran A, Fuentes-Andion M, et al. Biotechnology and biomaterial-based therapeutic strategies for age-related macular degeneration. Part I: biomaterials-based drug delivery devices. Front Bioeng Biotechnol. 2020; 8: 549089. doi:10.3389/fbioe.2020.549089.
   PubMed Web of Science ®Google Scholar
• Kelly E, Wen Q, Haddad D, et al. Effects of an aging population and racial demographics on eye disease prevalence: projections for Georgia through 2050. Am J Ophthalmol. 2020; 210: 35–40. doi:10.1016/j.ajo.2019.10.028.
   PubMed Web of Science ®Google Scholar
• Marshall AC. Traditional Chinese Medicine and Clinical Pharmacology. Cham: Springer International Publishing; 2020; 455–482.
   Google Scholar
• Wang X, Wang ZY, Zheng JH, et al. TCM network pharmacology: a new trend towards combining computational, experimental and clinical approaches. Chin J Nat Med. 2021; 19: 1–11. doi:10.1016/S1875-5364(21)60001-8.
   PubMed Web of Science ®Google Scholar
• Zhou X, Li CG, Chang D, et al. Current status and major challenges to the safety and efficacy presented by Chinese herbal medicine. Med (Basel). 2019; 6: 6. doi:10.3390/medicines6010014.
   Google Scholar
• Li Z, Wu Q, Xing Y. Key concepts in Traditional Chinese Medicine. Singapore: Palgrave Macmillan UK; 2019.
   Google Scholar
• Liu Z, Liu L. Essentials of Chinese medicine. New York: Springer; 2009. doi:10.1007/978-1-84882-590-1.
   Google Scholar
• Jiang P-F, Peng J, Zhou Y-S, et al. Ophthalmic syndrome differentiation system and digital Chinese medicine. Digital Chin Med. 2018; 1: 9–13. doi:10.1016/S2589-3777(19)30003-5.
   Google Scholar
• Wei Q, Rosenfarb A, Liang L. Ophthalmology in Chinese Medicine. Beijing: People’s Medical Publishing House; 2011.
   Google Scholar
• Law SK, Wang L, Li T. Acupuncture for glaucoma. Cochrane Database Syst Rev. 2020; 2: Cd006030. doi:10.1002/14651858.CD006030.pub4.
   PubMedGoogle Scholar
• Cooper R, Che C-T, Mok D-W, et al. Chinese and botanical medicines : traditional uses and modern scientific approaches. Boca Raton: CRC Press; 2018. doi:10.1201/9781315118956.
   Google Scholar
• Acott TS, Vranka JA, Keller KE, et al. Normal and glaucomatous outflow regulation. Prog Retin Eye Res. 2021; 82: 100897. doi:10.1016/j.preteyeres.2020.100897.
   PubMed Web of Science ®Google Scholar
• Quaranta L, Bruttini C, Micheletti E, et al. Glaucoma and neuroinflammation: an overview. Surv Ophthalmol. 2021; 66: 693–713. doi:10.1016/j.survophthal.2021.02.003.
   PubMed Web of Science ®Google Scholar
• Kang JM, Tanna AP. Glaucoma. Med Clin North Am. 2021; 105: 493–510. doi:10.1016/j.mcna.2021.01.004.
   PubMed Web of Science ®Google Scholar
• Huang J, Yu W, He Q, et al. Autophagy facilitates age-related cell apoptosis-a new insight from senile cataract. Cell Death Dis. 2022; 13: 37. doi:10.1038/s41419-021-04489-8.
   PubMed Web of Science ®Google Scholar
• Arbabi A, Bao X, Shalaby WS, et al. Systemic side effects of glaucoma medications. Clin Exp Optom. 2022; 105: 157–165. doi:10.1080/08164622.2021.1964331.
   PubMed Web of Science ®Google Scholar
• Gupta D, Chen PG. Glaucoma. Am Fam Physician. 2016; 93: 668–674.
   PubMed Web of Science ®Google Scholar
• Chao L, Na L, Bin L, et al. A meta-analysis of neuroprotective effect for Traditional Chinese Medicine (TCM) in the treatment of glaucoma. Open Med (Wars). 2016; 11: 25–30. doi:10.1515/med-2016-0006.
   PubMedGoogle Scholar
• Wang ZB. Progression study of Chinese Medicine on glaucoma [article in Chinese]. J China Prescription Drug. 2017; 15: 28–29.
   Google Scholar
• Hirooka K, Tokuda M, Miyamoto O, et al. The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma. Curr Eye Res. 2004; 28: 153–157. doi:10.1076/ceyr.28.3.153.26246.
   PubMed Web of Science ®Google Scholar
• Quaranta L, Bettelli S, Uva MG, et al. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003; 110: 359–362. doi:10.1016/S0161-6420(02)01745-1.
   PubMed Web of Science ®Google Scholar
• Williams RJ, Spencer JPE, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med. 2004; 36: 838–849. doi:10.1016/j.freeradbiomed.2004.01.001.
   PubMed Web of Science ®Google Scholar
• Wojtunik KA, Ciesla LM, Waksmundzka-Hajnos M. Model studies on the antioxidant activity of common terpenoid constituents of essential oils by means of the 2,2-diphenyl-1-picrylhydrazyl method. J Agric Food Chem. 2014; 62: 9088–9094. doi:10.1021/jf502857s.
   PubMed Web of Science ®Google Scholar
• Cybulska-Heinrich AK, Mozaffarieh M, Flammer J. Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma. Mol Vis. 2012; 18: 390–402.
   PubMed Web of Science ®Google Scholar
• Guo X, Kong X, Huang R, et al. Effect of Ginkgo biloba on visual field and contrast sensitivity in Chinese patients with normal tension glaucoma: a randomized, crossover clinical trial. Invest Ophthalmol Visual Sci. 2014; 55: 110–116. doi:10.1167/iovs.13-13168.
   PubMed Web of Science ®Google Scholar
• DewiSari M, Sihotang AD, Lelo A. Ginkgo biloba extract effect on oxidative stress marker malonildialdehyde, redox enzyme gluthation peroxidase, visual field damage, and retinal nerve fiber layer thickness in primary open angle glaucoma. Int J PharmTech Res. 2016; 9: 158–166.
   Google Scholar
• Quaranta L, Bettelli S, Uva MG, et al. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmol (Rochester, Minn). 2003; 110: 359–362. doi:10.1016/S0161-6420(02)01745-1.
   PubMed Web of Science ®Google Scholar
• Smith CA, Vianna JR, Chauhan BC. Assessing retinal ganglion cell damage. Eye (Lond). 2017; 31: 209–217. doi:10.1038/eye.2016.295.
   PubMed Web of Science ®Google Scholar
• Chan H-C, Chang R-C, Ip A-C, et al. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma. Exp Neurol. 2007; 203: 269–273. doi:10.1016/j.expneurol.2006.05.031.
   PubMed Web of Science ®Google Scholar
• Chu PH, Li HY, Chin MP, et al. Effect of Lycium barbarum (wolfberry) polysaccharides on preserving retinal function after partial optic nerve transection. PLoS One. 2013; 8: e81339. doi:10.1371/journal.pone.0081339.
   PubMed Web of Science ®Google Scholar
• Liu L, Sha XY, Wu YN, et al. Lycium barbarum polysaccharides protects retinal ganglion cells against oxidative stress injury. Neural Regen Res. 2020; 15: 1526–1531. doi:10.4103/1673-5374.274349.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Su G, Nie L, et al. Salvia miltiorrhiza extracts protect against retinal injury in a rat glaucoma model. Exp Ther Med. 2014; 7: 1513–1515. doi:10.3892/etm.2014.1632.
   PubMed Web of Science ®Google Scholar
• Shahzad M, Shabbir A, Wojcikowski K, et al. The antioxidant effects of Radix Astragali (Astragalus membranaceus and related species) in protecting tissues from injury and disease. Curr Drug Targets. 2016; 17: 1331–1340. doi:10.2174/1389450116666150907104742.
   PubMed Web of Science ®Google Scholar
• Yin L, Gao J. Protective effects of Radix Astragali on retinal ganglion cells of high intraocular pressure rats [Article in Chinese]. Beijing Zhong yi yao da xue xue bao. 2016; 39: 828–832. doi:10.1038/hr.2016.108.
   Google Scholar
• Feng K, Yu J, Tan K. Study on the protective effect of ligustrazine on retinal ganglion cells in rats with chronic ocular hypertension. Modern J Integr Tradit Chin West Med. 2017; 26: 935–938.
   Google Scholar
• Liang J, Wan X. Effects of tetramethylpyrazine on retinal ganglion cells apoptosis induced by chronic elevated-intraocular pressure in rats [Article in Chinese]. Recent Adv Ophthalmol. 2013; 33: 717–720.
   Google Scholar
• Pan L, Sze YH, Yang M, et al. Baicalein-A potent pro-homeostatic regulator of microglia in retinal ischemic injury. Front Immunol. 2022; 13: 837497. doi:10.3389/fimmu.2022.837497.
   PubMed Web of Science ®Google Scholar
• H-L L, Shan SW, Stamer WD, et al. Mechanistic effects of baicalein on aqueous humor drainage and intraocular pressure. Int J Mol Sci. 2022; 23: 7372. doi:10.3390/ijms23137372.
   PubMed Web of Science ®Google Scholar
• Francis BA, Hong B, Winarko J, et al. Vision loss and recovery after trabeculectomy: risk and associated risk factors. Arch Ophthalmol. 2011; 129: 1011–1017. doi:10.1001/archophthalmol.2011.182.
   PubMedGoogle Scholar
• Wu H, Xu J, Du X, et al. Shihu Yeguang Pill protects against bright light-induced photoreceptor degeneration in part through suppressing photoreceptor apoptosis. Biomed Pharmacother. 2020; 126: 110050. doi:10.1016/j.biopha.2020.110050.
   PubMed Web of Science ®Google Scholar
• Liu F, Gong H, Liu Z, et al. A study of modified Shihu Yeguang pill on 28 post-surgery end-stage glaucoma patients [Article in Chinese]. Hunan Zhong yi za zhi. 2005; 21: 22–25.
   Google Scholar
• Huang D, Chen Y. Network pharmacological study on the active ingredients and possible targets of Fuming tablet in the treatment of glaucoma [Article in Chinese]. J Shantou Univ Med Coll. 2020; 33: 75–78.
   Google Scholar
• Xu W, Yuan L, Jia H. Effect of fuming tablet on optic nerve regeneration in post-surgery glaucoma [Article in Chinese]. Pract Clin J Integr Tradit Chin West Med. 2009; 9: 41–42.
   Google Scholar
• Xing I, Liu X, Tang J. Treatment of fuming tablet on early stage and midstage glaucoma patients [Article in Chinese]. Chin Pharm. 2008; 17: 65–66.
   Google Scholar
• Khan A, Khan M, Halim SA, et al. Quinazolinones as competitive inhibitors of carbonic anhydrase-II (human and bovine): synthesis, in-vitro, in-silico, selectivity, and kinetics studies. Front Chem. 2020; 8: 598095. doi:10.3389/fchem.2020.598095.
   PubMed Web of Science ®Google Scholar
• Liu H, Li X, Zhang Z, et al. Efficacy and safety of Bujing Yishi tablet for glaucoma with controlled IOP: study protocol for a multi-centre randomized controlled trial. Trials. 2020; 21: 423. doi:10.1186/s13063-020-04249-7.
   PubMedGoogle Scholar
• Chen T, Ma N. Clinical observation of the combined use of Bujing Yishi tablet and mecobalamin on glaucoma [Article in Chinese]. Shanxi Zhong yi. 2015; 36: 1385–1386.
   Google Scholar
• Dong DQ, Chen G, Hou XW. Clinical observation of the combination of phacoemulsification and trabeculectomy. Zhonghua Yan Ke Za Zhi. 2004; 40: 295–298.
   PubMedGoogle Scholar
• Yamazaki Y, Hayamizu F, Tanaka C. Effects of long-term methylcobalamin treatment on the progression of visual field defects in normal-tension glaucoma. Curr Ther Res. 2000; 61: 443–451. doi:10.1016/S0011-393X(00)80027-2.
   Web of Science ®Google Scholar
• Xiang y, Liu J, Peng J, et al. Effect of Qingguangan granules on intraocular pressure of spontaneous glaucoma mice [Article in Chinese]. Hunan Zhong yi yao da xue xue bao. 2018; 38: 17–20.
   Google Scholar
• G B D Blindness Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health. 2021; 9: e144–e160. doi:10.1016/S2214-109X(20)30489-7.
   PubMed Web of Science ®Google Scholar
• Budnar P, Tangirala R, Bakthisaran R, et al. Protein aggregation and cataract: role of age-related modifications and mutations in α-crystallins. Biochem (Moscow). 2022; 87: 225–241. doi:10.1134/S000629792203004X.
   PubMed Web of Science ®Google Scholar
• Chen X, Xu J, Chen X, et al. Cataract: advances in surgery and whether surgery remains the only treatment in future. Adv Ophthalmol Pract Res. 2021; 1: 100008. doi:10.1016/j.aopr.2021.100008.
   PubMedGoogle Scholar
• Age-Related Eye Disease Study 2 Research G, Chew EY, SanGiovanni JP, et al. Lutein/Zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. JAMA Ophthalmol. 2013; 131: 843–850. doi:10.1001/jamaophthalmol.2013.4412.
   PubMed Web of Science ®Google Scholar
• Chan CC. Couching for cataract in China. Surv Ophthalmol. 2010; 55: 393–398. doi:10.1016/j.survophthal.2010.02.001.
   PubMed Web of Science ®Google Scholar
• Kinoshita JH. Mechanisms initiating cataract formation. Proctor lecture. Invest Ophthalmol. 1974; 13: 713–724.
   PubMedGoogle Scholar
• Yao Q, Zhou Y, Yang Y, et al. Activation of Sirtuin1 by lyceum barbarum polysaccharides in protection against diabetic cataract. J Ethnopharmacol. 2020; 261: 113165. doi:10.1016/j.jep.2020.113165.
   PubMed Web of Science ®Google Scholar
• Xie Q, Xue L, Cao X, et al. Apoptosis of lens epithelial cells and expression of NLRP3-related proteins in patients with diabetes and cataract. Ocul Immunol Inflamm. 2022; 31: 1–8. doi:10.1080/09273948.2022.2079537.
   Web of Science ®Google Scholar
• Luo J-P, Deng Y-Y, Zha X-Q. Mechanism of polysaccharides from dendrobium huoshanense. On streptozotocin-induced diabetic cataract. Pharm Biol. 2008; 46: 243–249. doi:10.1080/13880200701739397.
   Web of Science ®Google Scholar
• Hashim Z, Zarina S. Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract. Age. 2011; 33: 377–384. doi:10.1007/s11357-010-9177-1.
   PubMedGoogle Scholar
• Stitt AW. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol. 2001; 85: 746. doi:10.1136/bjo.85.6.746.
   PubMed Web of Science ®Google Scholar
• Liu F, Tian M. Study on the mechanism of Qiju Dihuang pill in the treatment of ophthalmic diseases based on systems pharmacology. Medicine. 2022; 101: e30033. doi:10.1097/MD.0000000000030033.
   PubMed Web of Science ®Google Scholar
• Huang J. Observational study of Qiju Dihuang pill on the development of age-related macular degeneration [Article in Chinese]. Asian Pac J Trop Med. 2007; 3: 40–41.
   Google Scholar
• Upaphong P, Thonusin C, Choovuthayakorn J, et al. The possible positive mechanisms of pirenoxine in cataract formation. Int J Mol Sci. 2022; 23: 1–21. doi:10.3390/ijms23169431.
   Web of Science ®Google Scholar
• Liu Y, Wnag L, Li I, et al. Clinical observational study of Qiju Dihuang pill on age-related cataract patients [Article in Chinese]. Pharmacol Clin Chin Mater Med. 2017; 32: 193–195.
   Google Scholar
• Yadav S, Tandon R. Comprehensive eye examination: what does it mean? Community Eye Health. 2019; 32: S1–S4.
   PubMedGoogle Scholar
• Qi L, Lin Y, Xu G, et al. Effect of shijueming on SOD,GSH and GSH-PX in cataract lens of rats [Article in Chinese]. Asian Pac J Trop Med. 2011; 11: 2085–2087.
   Google Scholar
• Liu Y. Common Traditional Chinese Medicine and its pharmacology in ophthalmology [Book in Chinese]. China: Jinan publisher; 2001.
   Google Scholar
• Ma L, Wang B, Long Y, et al. Effect of Traditional Chinese Medicine combined with Western therapy on primary hepatic carcinoma: a systematic review with meta-analysis. Front Med. 2017; 11: 191–202. doi:10.1007/s11684-017-0512-0.
   PubMed Web of Science ®Google Scholar
• Yang M, Cheng M, Wang M, et al. Meta-analysis of the effect of Traditional Chinese Medicine compounds combined with standard Western medicine for the treatment of diabetes mellitus complicated by coronary heart disease. Evid Based Complementary Altern Med. 2021; 2021: 1–12. doi:10.1155/2021/5515142.
   Web of Science ®Google Scholar
• Su HF, Shaker S, Kuang Y, et al. Phytochemistry and cardiovascular protective effects of Huang-Qi (Astragali Radix). Med Res Rev. 2021; 41: 1999–2038. doi:10.1002/med.21785.
   PubMed Web of Science ®Google Scholar
• Ren J, Fu L, Nile SH, et al. Salvia miltiorrhiza in treating cardiovascular diseases: a review on its pharmacological and clinical applications. Front Pharmacol. 2019; 10: 753. doi:10.3389/fphar.2019.00753.
   PubMed Web of Science ®Google Scholar
• Gu WB. Clinical ophthalmology in Traditional Chinese Medicine [Book in Chinese]. China: Xinjiang technology and health publisher; 1997.
   Google Scholar
• Yang J, Y-Q W, J-B D, et al. Research and application of Lycii Fructus in medicinal field. Chin Herb Med. 2018; 10: 339–352. doi:10.1016/j.chmed.2018.08.006.
   Web of Science ®Google Scholar
• Zhao ZZ, Xiao PG. Encyclopedia of medicinal plants [Book in Chinese]. Hong Kong: Hong Kong Jockey Club. Institute of Chinese Medicine; 2006.
   Google Scholar
• Naccarato M, Yoong D, Gough K. A potential drug-herbal interaction between Ginkgo biloba and efavirenz. J Int Assoc Physicians AIDS Care (Chic). 2012; 11: 98–100. doi:10.1177/1545109711435364.
   PubMedGoogle Scholar
• Leng CY. Clinical observation of the combined use of Qiju Dihuang pill and polyethylene glycol eye drops in type 2 diabetic patients with dry eye diseases [Article in Chinese]. Diabetes New World. 2018; 21: 65–66.
   Google Scholar
• Zhang M, Ning X-L, Ning X-H. Combination of Western medicine and modified zhujingwan decoction for age-related macular degeneration [Article in Chinese]. J Guangdong Med Coll. 2016; 34: 305–307.
   Google Scholar
• Bian ZX, Moher D, Li YP, et al. Appropriately selecting and concisely reporting the outcome measures of randomized controlled trials of Traditional Chinese Medicine. Zhong Xi Yi Jie He Xue Bao. 2008; 6: 771–775. doi:10.3736/jcim20080801.
   PubMedGoogle Scholar
• Bian ZX, Moher D, Li YP, et al. Precise reporting of Traditional Chinese Medicine interventions in randomized controlled trials. Zhong Xi Yi Jie He Xue Bao. 2008; 6: 661–667. doi:10.3736/jcim20080701.
   PubMedGoogle Scholar
• Center for Drug Evaluation and Research. Botanical drug development: guidance for industry. In: Food and Drug Administration; 2016.
   Google Scholar
• Li X, Chen Y, Lai Y, et al. Sustainable utilization of Traditional Chinese Medicine resources: systematic evaluation on different production modes. Evid Based Complement Alternat Med. 2015; 2015: 218901. doi:10.1155/2015/218901.
   PubMed Web of Science ®Google Scholar
• Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014; 4: 177. doi:10.3389/fphar.2013.00177.
   PubMed Web of Science ®Google Scholar
• Cheng TF, Jia YR, Zuo Z, et al. Quality assessment of Traditional Chinese Medicine herb couple by high-performance liquid chromatography and mass spectrometry combined with chemometrics. J Sep Sci. 2016; 39: 1223–1231. doi:10.1002/jssc.201501259.
   PubMedGoogle Scholar
• Seo C-S, Shin H-K. Development and validation of a high-performance liquid chromatography method for quality assessment of oriental medicine, Dokhwalgisaeng-Tang. Appl Sci. 2021; 11: 7829. doi:10.3390/app11177829.
   Google Scholar
• Mok DKW, Chau F-T. Chemical information of Chinese medicines: a challenge to chemist. Chemometr Intell Lab Sys. 2006; 82: 210–217. doi:10.1016/j.chemolab.2005.05.006.
   Web of Science ®Google Scholar
• Luo TT, Lu Y, Yan SK, et al. Network pharmacology in research of Chinese medicine formula: methodology, application and prospective. Chin J Integr Med. 2020; 26: 72–80. doi:10.1007/s11655-019-3064-0.
   PubMed Web of Science ®Google Scholar
• Evangelho K, Mastronardi CA, de-la-Torre A. Experimental models of glaucoma: a powerful translational tool for the future development of new therapies for glaucoma in humans—a review of the literature. Medicina (Kaunas). 2019; 55: 280. doi:10.3390/medicina55060280.
   PubMed Web of Science ®Google Scholar
• Pan Z, Li M, Jin Z, et al. Research status of Chinese medicine formula based on network pharmacology. Pharmacol Res - Mod Chin Med. 2022; 4: 100132. doi:10.1016/j.prmcm.2022.100132.
   Google Scholar